ContractLease Agreement • August 7th, 2023 • Prime Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 7th, 2023 Company Industry
Tenth Amendment to License AgreementLicense Agreement • August 7th, 2023 • Prime Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 7th, 2023 Company IndustryThis Tenth Amendment to License Agreement (“Tenth Amendment”) is made as of April 14, 2023, by and between Prime Medicine, Inc. (“Licensee”) and MIL 21E, LLC (“Licensor”).
Nineth Amendment to License AgreementLicense Agreement • August 7th, 2023 • Prime Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 7th, 2023 Company IndustryThis Nineth Amendment to License Agreement (“Nineth Amendment”) is dated March 17, 2023 (“Effective Date”) and entered into by and between Prime Medicine, Inc. (“Licensee”) and MIL 21E, LLC (“Licensor”).
Eleventh Amendment to License AgreementLicense Agreement • August 7th, 2023 • Prime Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 7th, 2023 Company IndustryThis Eleventh Amendment to License Agreement (“Eleventh Amendment”) is dated May 4, 2023 (“Effective Date”) and entered into by and between Prime Medicine, Inc. (“Licensee”) and MIL 21E, LLC (“Licensor”).
Sixth Amendment to License AgreementLicense Agreement • August 7th, 2023 • Prime Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 7th, 2023 Company IndustryThis Sixth Amendment to License Agreement is dated April 5, 2022 (“Sixth Amendment”) and is entered into between Prime Medicine, Inc. (“Licensee”) and MIL 21E, LLC (“Licensor”).